➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Mallinckrodt
Colorcon
Medtronic
Moodys

Last Updated: June 14, 2021

DrugPatentWatch Database Preview

OCTAGAM IMMUNE GLOBULIN (HUMAN) Drug Profile


Email this page to a colleague

« Back to Dashboard

Summary for Tradename: OCTAGAM IMMUNE GLOBULIN (HUMAN)
Patents:105
Applicants:1
BLAs:1
Suppliers: see list1

Patent Text Search: US Patents for OCTAGAM IMMUNE GLOBULIN (HUMAN)

These patents were identified by searching patent claims

Supplementary Protection Certificates for OCTAGAM IMMUNE GLOBULIN (HUMAN)

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
132016000070123 Italy   Get Started Free PRODUCT NAME: RITUXIMAB IN ASSOCIAZIONE CON IALURONIDASI RICOMBINANTE UMANA - SOLUZIONE PER INIEZIONE SOTTOCUTANEA(MABTHERA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/98/067/001-003, 20140326
284 1-2017 Slovakia   Get Started Free PRODUCT NAME: KOBICISTAT VO VSETKYCH FORMACH CHRANENYCH ZAKLADNYM PATENTOM/DARUNAVIR VO VSETKYCH FORMACH CHRANENYCH ZAKLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/14/967 20141121
CA 2017 00003 Denmark   Get Started Free PRODUCT NAME: COBICISTAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF OG ATAZANAVIR ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER ATAZANAVIRSULFAT; REG. NO/DATE: EU/1/15/1025/001-002 20150715
2004/004 Ireland   Get Started Free PRODUCT NAME: ADALIMUMAB; NAT REGISTRATION NO/DATE: EU/1/03/257/001-006 20030901; FIRST REGISTRATION NO/DATE: CH 56221 20030416
122015000061 Germany   Get Started Free PRODUCT NAME: TRASTUZUMAB UND RECOMBINANTE HUMANE HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Express Scripts
AstraZeneca
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.